Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BTA-EG6 is a novel catalase-amyloid interaction inhibitor, penetrating the blood-brain barrier and protecting cells from Aβ-induced toxicity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | BTA-EG6 is a novel catalase-amyloid interaction inhibitor, penetrating the blood-brain barrier and protecting cells from Aβ-induced toxicity. |
Molecular Weight | 504.64 |
Formula | C26H36N2O6S |
CAS No. | 921193-29-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BTA-EG6 921193-29-5 BTA EG6 BTAEG6 inhibitor inhibit